quipazine has been researched along with u-50488 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ignar, DM; Kuhn, CM; Windh, RT | 1 |
Jackisch, R; Riegert, C; Rothmaier, AK; Rutz, S | 1 |
2 other study(ies) available for quipazine and u-50488
Article | Year |
---|---|
Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aging; Analgesics; Animals; Animals, Newborn; Corticosterone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Hypothalamo-Hypophyseal System; Morphine; Physostigmine; Pituitary-Adrenal System; Pyrrolidines; Quipazine; Rats; Rats, Inbred Strains | 1992 |
Presynaptic modulation of 5-HT release in the rat septal region.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Brimonidine Tartrate; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; In Vitro Techniques; Male; Neurons; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Quipazine; Rats; Rats, Wistar; Septum of Brain; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2007 |